| Listed site | both | cro |
|---|
| Summary | Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany. | ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds. |
|---|
| Services | - Bioinformatics & Data Science
- High-Throughput Screening
- Target Identification & Validation
- Discovery Research
- GLP Toxicology
- In Vivo PK / PD Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- In Vitro Pharmacology
- Oligonucleotide Manufacturing
- Process Development
- CMC Analytical Development
- Technology Transfer
| - Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- Safety Pharmacology
- GLP Toxicology
- Specialized & Large-Animal Models
- Translational Research
|
|---|
| Modalities | | - Small Molecule
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Gene Therapy
|
|---|
| Indications | Data not yet provided. | - Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
|
|---|
| Locations | - Petaluma, Petaluma, California, USA
- Berlin, Berlin, Berlin, Germany
- Kulmbach, Kulmbach, Bavaria, Germany
| - Headquarters, San Diego, CA, USA
- Representative - South Korea, Seongnam-si, Gyeongi-do, South Korea
- Representative - Japan, Tokyo, Tokyo, Japan
- Representative - China, Shanghai, Shanghai, China
|
|---|
| Certifications | - GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
- GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
| - GLP · Identifier: GLP compliant
- CMP · Identifier: CMP compliant
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|